We've now heard from all of the big banks, so on this week's Industry Focus: Financials, Matt and Jason are digging into the results. They're diving into the latest numbers from JPMorgan Chase (NYSE: JPM), Bank of America (NYSE: BAC), Wells Fargo (NYSE: WFC), and Goldman Sachs (NYSE: GS). Plus, we just learned that Bill Ackman's SPAC deal isn't going to happen, so what does it mean for Pershing Square Tontine Holdings (NYSE: PSTH) and its shareholders?

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Almost a quarter of our shows so far in 2021 have been breakdowns of newly public companies.

On today's show, we revisit all the businesses we looked at in the first half of the year, get up to speed on their latest results, and talk about which ones are our favorites.

Stocks: OLO, PATH, S, GLBE, SQSP, KNBE, RAAC, AFRM.

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

NPR’s Jacob Goldstein returns to the show for a wide-ranging conversation with Jason Hall and Nick Sciple about the cryptocurrency market, inflation, housing, and more. 

Investments Discussed: Bitcoin

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

HyperFine is looking to head to public markets with the lofty goal of disrupting the MRI market with the first FDA-approved portable MRI machine. Join Brian Feroldi and Emily Flippen as they break down HyperFine’s roadshow and unpack this recent SPAC. 

Stocks: HealthCor Catalio Acquisition Corp (HCAQ)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Crocs is perhaps the most controversial footwear brand of all time, creating both blind loyalists and uncompromising cynics. Regardless of what side of the fence you may fall on, Crocs have skyrocketed in popularity over the past few years as brand deals, endorsements, and Gen Z flocked to the Croc. Join Motley Fool Analysts Asit Sharma and Emily Flippen as they take a look at where Crocs has been and if the best is still yet to come.

*** Editor's note: In the podcast and in the accompanying transcript below, our analysts described Croc's Croslite formulation as "patented." This was an error. Croc's croslite formulation is proprietary, but not patented.

Stocks: Crocs (CROX)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Wells Fargo (NYSE: WFC) recently decided to shut down its personal lines of credit business. Why did the bank make this move, and is it unfair to customers? Plus, SPACs are back in the news after Virgin Galactic's (NYSE: SPCE) successful flight with founder Richard Branson. Plus, host Jason Moser and Fool.com contributor discuss what they'll be watching as banks report their earnings later this week. 

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

We talk Duolingo (and a bit of Spanish and French) on today's episode.

Listen in for a breakdown of how this app uses the freemium model to make language education easy and accessible, whether the company's books look bien or mal, and why the CEO's track record is something to be excited about.

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Motley Fool Senior Analyst John Rotonti joins the podcast to break down the industrial gas industry and the case for investing in industrial gas giant (and Dividend Aristocrat) Linde.

Stocks Discussed: LIN, APD, AIQUY

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Join Brian Feroldi as he walks you through three small cap healthcare companies that may have flown under your radar with the aim of answering the question every investor wants to know: can this business result in 10x returns? 

Stocks: Progyny (PGNY), Pulmonx (LUNG), and Nano-X Imaging (NNOX)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]

Join Analysts Asit Sharma and Emily Flippen as they take a look at the online dating industry, including dating trends coming out of the coronavirus pandemic as well as two of the biggest competitors: Match Group (MTCH) and Bumble (BMBL)

Check out more of our content here:

Podcasts

Youtube

Twitter

Reach us by Email @ [email protected]